Clinical usefulness of adjusted D-dimer cut-off values to exclude pulmonary embolism in a community hospital emergency department patient population

Acta Radiol. 2012 Sep 1;53(7):765-8. doi: 10.1258/ar.2012.120105. Epub 2012 Jul 3.

Abstract

Background: Plasma D-dimer measurement is used in the assessment of the clinical probability of pulmonary embolism (PE), in order to minimize the requirement for pulmonary computed tomography angiography (CTA).

Purpose: To evaluate whether doubling the threshold value of serum D-dimer from 500 μg/L to 1000 μg/L could safely reduce utilization of pulmonary CTA to exclude PE in our emergency department patient population.

Material and methods: Emergency department patients evaluated for PE with a quantitative D-dimer assay and pulmonary CTA were eligible for inclusion. D-dimer values were retrospectively collected in all included patients. Pulmonary CT angiograms were reviewed and scored as positive or negative for PE. Receiver-operating characteristic (ROC) analysis was used to determine the accuracy of quantitative D-dimer measurements in differentiating between positive and negative PE patients as per CTA.

Results: A total of 237 consecutive patients underwent pulmonary CTA and had a D-dimer measurement performed. Median D-dimer level was 1007 μg/L and in 11 (5%) patients the pulmonary CT CTA was positive for PE. The ROC curve showed an area under the curve (AUC) of 0.91 (P < 0.0001). Increasing the D-dimer threshold value of 500 μg/L to 1000 μg/L increased the specificity from 8% to 52% without changing the sensitivity.

Conclusion: Adjusting the D-dimer cut-off value for the emergency department community population and patient age increases the yield and specificity of the ELISA D-dimer assay for the exclusion of PE without reducing sensitivity.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Chi-Square Distribution
  • Contrast Media
  • Emergency Service, Hospital
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fibrin Fibrinogen Degradation Products / metabolism*
  • Hospitals, Community
  • Humans
  • Iohexol
  • Male
  • Middle Aged
  • Pulmonary Embolism / blood*
  • Pulmonary Embolism / diagnostic imaging
  • ROC Curve
  • Retrospective Studies
  • Sensitivity and Specificity
  • Statistics, Nonparametric
  • Tomography, X-Ray Computed / statistics & numerical data*

Substances

  • Biomarkers
  • Contrast Media
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • Iohexol